Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-01-007855
Filing Date
2001-03-21
Accepted
2001-03-21 00:00:00
Documents
10
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 10K_1140 a2041385z10-k405.txt 10-K405 279026
2 EXHIBIT 10.1 a2041385zex-10_1.txt EX-10.1 973
3 EXHIBIT 10.10 a2041385zex-10_10.txt EX-10.10 183344
4 EXHIBIT 10.11 a2041385zex-10_11.txt EX-10.11 188007
5 EXHIBIT 10.12 a2041385zex-10_12.txt EX-10.12 14565
6 EXHIBIT 10.13 a2041385zex-10_13.txt EX-10.13 27355
7 EXHIBIT 10.14 a2041385zex-10_14.txt EX-10.14 8538
8 EXHIBIT 13.1 a2041385zex-13_1.txt EX-13.1 40355
9 EXHIBIT 21.1 a2041385zex-21_1.txt EX-21.1 2445
10 EXHIBIT 23.1 a2041385zex-23_1.txt EX-23.1 369
  Complete submission text file 0000912057-01-007855.txt   747519
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

EIN.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-25317 | Film No.: 1573908
SIC: 2836 Biological Products, (No Diagnostic Substances)